NantHealth Inc. (NH)

0.59
0.00 0.36
NASDAQ : Technology Services
Prev Close 0.58
Open 0.58
Day Low/High 0.56 / 0.62
52 Wk Low/High 0.48 / 3.64
Volume 76.66K
Avg Volume 351.40K
Exchange NASDAQ
Shares Outstanding 109.93M
Market Cap 64.16M
EPS -1.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

NantHealth® Showcases Connected Care Benefits To Improve Medical Device Data Collection At The American Nursing Informatics Association (ANIA) Annual Conference

NantHealth® Showcases Connected Care Benefits To Improve Medical Device Data Collection At The American Nursing Informatics Association (ANIA) Annual Conference

NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, will present on Connected Care VitalsConX technology at the American Nursing Informatics Association (ANIA) Annual Conference taking place April 12-13, 2019...

NantHealth Reports 2018 Fourth-Quarter, Full-Year Financial Results

NantHealth Reports 2018 Fourth-Quarter, Full-Year Financial Results

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its fourth quarter ended December 31, 2018.

NantHealth To Report 2018 Fourth-Quarter Financial Results And Host Conference Call On Thursday, March 28

NantHealth To Report 2018 Fourth-Quarter Financial Results And Host Conference Call On Thursday, March 28

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2018 fourth quarter on Thursday, March 28, 2019, after market close.

NantHealth® And Northwest Fire Fighters Benefits Trust (NWFFT) Join Forces To Provide GPS Cancer® And Liquid GPS To Trust Covered Members

NantHealth® And Northwest Fire Fighters Benefits Trust (NWFFT) Join Forces To Provide GPS Cancer® And Liquid GPS To Trust Covered Members

NantHealth, Inc. (NASDAQ: NH), announced an agreement with Northwest Fire Fighters Benefits Trust (NWFFT), one of the largest firefighter healthcare trusts in the U.

NantHealth® And NantOmics To Reveal New Research Demonstrating Importance Of Examining RNA Expression And Individual Biomarkers In Cancer Testing

NantHealth® And NantOmics To Reveal New Research Demonstrating Importance Of Examining RNA Expression And Individual Biomarkers In Cancer Testing

Scientific teams from NantHealth ( NASDAQ: NH) and NantOmics will present two posters at the American Society of Clinical Oncology's (ASCO) Genitourinary Cancers Symposium this week.

NantHealth® Debuts Multiple Connected Care Initiatives At HIMSS

NantHealth® Debuts Multiple Connected Care Initiatives At HIMSS

NantHealth, Inc. (NASDAQ: NH), a leader in connected care solutions, will unveil a series of new initiatives designed to improve patient outcomes and provider satisfaction at the 2019 Healthcare Information and Management Systems Society (HIMSS) Annual...

NantHealth® To Present New Research Findings At The San Antonio Breast Cancer Symposium

NantHealth® To Present New Research Findings At The San Antonio Breast Cancer Symposium

Significant developments in breast cancer research will be presented by NantHealth (NASDAQ: NH) at the San Antonio Breast Cancer Symposium this week.

NantHealth Reports 2018 Third-Quarter Financial Results

NantHealth Reports 2018 Third-Quarter Financial Results

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its third quarter ended September 30, 2018.

NantHealth® Advances Clinician Productivity And Critical Patient Information Access With Enhancements To DeviceConX™

NantHealth® Advances Clinician Productivity And Critical Patient Information Access With Enhancements To DeviceConX™

NantHealth (NASDAQ: NH), a leader in breakthrough cancer research and data solutions that improve patient care and lower healthcare costs, today announced updates to its Connected Care portfolio of medical device integration (MDI) products, including...

NantHealth®, B. Braun Australia, GE Healthcare And IProcedures Join Forces To Bridge Connectivity Gap Between Patient Devices, Data And Medical Records At The Healthcare Information And Management Systems Society (HIMSS) Asia Pacific Conference

NantHealth®, B. Braun Australia, GE Healthcare And IProcedures Join Forces To Bridge Connectivity Gap Between Patient Devices, Data And Medical Records At The Healthcare Information And Management Systems Society (HIMSS) Asia Pacific Conference

NantHealth (NASDAQ: NH), a leader in breakthrough cancer research and solutions to improve patient care and lower healthcare costs, today announced a collaboration with B.

NantHealth To Report 2018 Third-Quarter Financial Results And Host Conference Call On Thursday, November 15

NantHealth To Report 2018 Third-Quarter Financial Results And Host Conference Call On Thursday, November 15

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2018 third quarter on Thursday, November 15, 2018, after market close.

NantHealth And NantOmics Present Four Research Papers Demonstrating Advancements In Cancer Diagnostics With NantHealth's GPS Cancer® And Liquid GPS™

NantHealth And NantOmics Present Four Research Papers Demonstrating Advancements In Cancer Diagnostics With NantHealth's GPS Cancer® And Liquid GPS™

Significant developments in cancer research were presented by NantHealth (NASDAQ: NH) and NantOmics at the ESMO conference in Munich, Germany this week.

NantHealth Announces Appointment Of Two Senior Executives To Lead Strategy, Business Development, And Global Sales

NantHealth Announces Appointment Of Two Senior Executives To Lead Strategy, Business Development, And Global Sales

NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company, announced new executive appointments to lead the company's strategy and business development as well as global sales.

Using The Technology That Powers GPS Cancer™, Scientists Have Developed Fresh Insights Into The Driving Mechanisms Of A Rare Skin Cancer

Using The Technology That Powers GPS Cancer™, Scientists Have Developed Fresh Insights Into The Driving Mechanisms Of A Rare Skin Cancer

New, peer-reviewed research utilizing NantOmics technology, which powers NantHealth's (NASDAQ: NH) GPS Cancer ® is giving scientists fresh insights into the driving mechanisms behind a form of rare skin cancer as well as therapies to treat patients.

NantHealth Reports 2018 Second-Quarter Financial Results

NantHealth Reports 2018 Second-Quarter Financial Results

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its second quarter ended June 30, 2018.

NantHealth To Report 2018 Second-Quarter Financial Results And Host Conference Call On Thursday, August 9

NantHealth To Report 2018 Second-Quarter Financial Results And Host Conference Call On Thursday, August 9

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2018 second quarter on Thursday, August 9, 2018, after market close.

NantHealth Unveils New Collaboration Tools - Provider Initiated Document Exchange And Authorization Appeals

NantHealth Unveils New Collaboration Tools - Provider Initiated Document Exchange And Authorization Appeals

NantHealth, Inc. (NASDAQ: NH) announced two exciting new product launches - Provider Initiated Document Exchange and Authorization Appeals - on the nation's leading payer-provider collaboration platform, NaviNet® Open, at the 2018 AHIP Institute and Expo.

NantHealth To Present And Exhibit On The Convergence Of Precision Medicine And Value-Based Care At America's Health Insurance Plans (AHIP) Institute & Expo 2018

NantHealth To Present And Exhibit On The Convergence Of Precision Medicine And Value-Based Care At America's Health Insurance Plans (AHIP) Institute & Expo 2018

NantHealth (NASDAQ: NH), a next-generation healthcare company, will exhibit and present at America's Health Insurance Plans ( AHIP) Institute & Expo 2018 taking place June 20-22, 2018 at the San Diego Convention Center in San Diego, CA at booth #824.

NantHealth And NantOmics To Present Data On The Frequency Of Non-Expressed Variants Tested By Standard NGS Panel At The American Society Of Clinical Oncology (ASCO) 2018 Annual Meeting

NantHealth And NantOmics To Present Data On The Frequency Of Non-Expressed Variants Tested By Standard NGS Panel At The American Society Of Clinical Oncology (ASCO) 2018 Annual Meeting

NantWorks, LLC today announced that its affiliate companies, NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company and NantOmics, LLC, the leader in molecular analysis and a member of the NantWorks...

NantHealth And NantOmics To Present Patterns Of Immune Checkpoint Molecules In Relation To PD-L1 Expression At The American Society Of Clinical Oncology (ASCO) 2018 Annual Meeting

NantHealth And NantOmics To Present Patterns Of Immune Checkpoint Molecules In Relation To PD-L1 Expression At The American Society Of Clinical Oncology (ASCO) 2018 Annual Meeting

NantWorks, LLC today announced that its affiliate companies, NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company and NantOmics, LLC, the leader in molecular analysis and a member of the NantWorks...

NantHealth Unveils Liquid GPS™, Powerful Next-Generation Tool For Blood-Based Tumor Profiling And Quantitative Monitoring

NantHealth Unveils Liquid GPS™, Powerful Next-Generation Tool For Blood-Based Tumor Profiling And Quantitative Monitoring

NantHealth, Inc. (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company, unveiled Liquid GPS™ a powerful next-generation tool for blood-based tumor profiling and quantitative monitoring.

NantOmics Announces Study Showing Signature Analysis That Reveals Three Distinct Classifications Of Skin Cancer Known As Sebaceous Carcinoma

NantOmics Announces Study Showing Signature Analysis That Reveals Three Distinct Classifications Of Skin Cancer Known As Sebaceous Carcinoma

NantOmics, LLC, the leader in molecular analyses and a member of the NantWorks ecosystem of companies, announced today the publication of peer-reviewed research defining for the first time three distinct classifications of sebaceous carcinoma, a rare and...

NantHealth To Present At The Bank Of America Merrill Lynch Health Care Conference 2018 On May 17

NantHealth To Present At The Bank Of America Merrill Lynch Health Care Conference 2018 On May 17

NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that its management will be presenting at the Bank of America Merrill Lynch 2018 Health Care Conference on Thursday, May 17, 2018, at...

NantHealth Showcases And Presents Its Portfolio Of Medical Device Integration (MDI) Products To Provide Current And Future Insights To Patient Care At The Largest E-Health Event In Scandinavia

NantHealth Showcases And Presents Its Portfolio Of Medical Device Integration (MDI) Products To Provide Current And Future Insights To Patient Care At The Largest E-Health Event In Scandinavia

NantHealth (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, showcased their Connected Care solutions at Vitalis, the largest e-health event in Scandinavia.

CORRECTING And REPLACING NantHealth Reports 2018 First-Quarter Financial Results

CORRECTING And REPLACING NantHealth Reports 2018 First-Quarter Financial Results

Changes have been made to the "Supplemental Revenue Schedule" and "Non-GAAP Net Loss and Non-GAAP Net Loss Per Share" financial tables.

NantHealth And NantOmics Announce Publication Of Study Highlighting High Error Rates In Tumor-Only Sequencing For Cancer Treatment

NantHealth And NantOmics Announce Publication Of Study Highlighting High Error Rates In Tumor-Only Sequencing For Cancer Treatment

NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company, and NantOmics, LLC, the leader in molecular diagnostics and a member of the NantWorks ecosystem of families, announced today joint results that...

TheStreet Quant Rating: D- (Sell)